Analysis of Effects and Side Effects in Patients Undergoing Radiation Therapy
NCT ID: NCT02500173
Last Updated: 2021-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1800 participants
OBSERVATIONAL
2015-06-01
2020-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study investigates how analysis of effects and side effects will influence outcome of patients. These retrospectively collected data allow to adapt and improve radiotherapy treatment regimens .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy
NCT05192876
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839
Patient Experience Data in Radiation Oncology
NCT05224297
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889
Measuring the Effect of Radiation Therapy on Patient Activity Levels
NCT02694380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiation
Radiation therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Age: \< 20 years, \> 105 years
20 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Graubuenden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel R Zwahlen, MD MBA
Role: STUDY_CHAIR
Kantonsspital Winterthur, Department of Radiation Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Graubuenden, Department of Radiaton Oncology
Chur, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr.2015-0221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.